Trader’s Recap – SINA (NASDAQ:SINA) , Arena Pharmaceuticals (NASDAQ:ARNA) , FelCor Lodging Trust (NYSE:FCH) , Anixter (NYSE:AXE) , Genomic (NASDAQ:GHDX)

SINA Corp (NASDAQ:SINA)‘s stock had its “neutral” rating reiterated by Zacks in a research report issued to clients and investors on Thursday. They currently have a $52.00 target price on the stock. Zacks‘s target price suggests a potential upside of 4.75% from the stock’s previous close. SINA Corp (NASDAQ:SINA) stock performance was -0.38% in last session and finished the day at $48.45. Traded volume was … Continue reading Trader’s Recap – SINA (NASDAQ:SINA) , Arena Pharmaceuticals (NASDAQ:ARNA) , FelCor Lodging Trust (NYSE:FCH) , Anixter (NYSE:AXE) , Genomic (NASDAQ:GHDX)

Volatile Stocks: Canadian Solar (NASDAQ:CSIQ), Genetic Technologies (NASDAQ:GENE), Dendreon (NASDAQ:DNDN), Arena Pharmaceuticals (NASDAQ:ARNA)

Canadian Solar Inc. (NASDAQ:CSIQ) on July 7th, 2014 announced that its wholly owned subsidiary, Canadian Solar Solutions Inc., on June 30th, completed the sale of the 10 MW AC solar photovoltaic (PV) power plant “Val Caron” valued at over CAD 60 million to One West Holdings Ltd., an affiliate of Concord Green Energy. Canadian Solar Inc. (NASDAQ:CSIQ) stock performance was -3.19% in last session and finished … Continue reading Volatile Stocks: Canadian Solar (NASDAQ:CSIQ), Genetic Technologies (NASDAQ:GENE), Dendreon (NASDAQ:DNDN), Arena Pharmaceuticals (NASDAQ:ARNA)

CliniWorks today announced a strategic alliance between and Pfizer Inc. (NYSE:PFE) to jointly advance the parties’ respective capabilities in working with healthcare provider organizations to identify and close clinical or quality gaps to improve population health. The two companies are partnering to develop a population health management platform solution that leverages CliniWorks’ technologies in disparate data aggregation and Natural Language Processing (which interprets free text … Continue reading Healthcare Active Movers: Pfizer Inc. (NYSE:PFE), Arena Pharmaceuticals (NASDAQ:ARNA), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)

Earlier this month, Vivus Inc. (NASDAQ:VVUS) said it filed a patent-infringement lawsuit against Actavis PLC ( ACT ) alleging that the drug maker’s planned generic version of weight-loss drug Qsymia infringes its patents. VIVUS, Inc. (NASDAQ:VVUS) stock performance was 3.97% in last session and finished the day at $5.50. Traded volume was 4.47million shares in the last session and the average volume of the stock remained 3.04million … Continue reading Health Stocks to Watch: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD), Eli Lilly (NYSE:LLY)

Drugmaker Vivus Inc. (NASDAQ:VVUS) said Thursday it has filed a lawsuit against Actavis PLC and its affiliates in a New Jersey federal court over its bid with the U.S. Food and Drug Administration to sell a generic version of company’ prescription weight-loss drug Qsymia. VIVUS, Inc. (NASDAQ:VVUS) stock performance was -0.19% in last session and finished the day at $5.17. Traded volume was 1.03million shares … Continue reading Hot Watch List: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Biogen Idec Inc (NASDAQ:BIIB)

Pfizer Inc (NYSE:PFE) was the target of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 59,856,772 shares, a growth of 14.0% from the April 30th total of 52,494,773 shares, StockRatingsNetwork.com reports. Currently, 0.9% of the shares of the company are sold short. Pfizer Inc. (NYSE:PFE) stock performance was -1.14% in last session and … Continue reading Healthcare Active Movers; Pfizer Inc. (NYSE:PFE), Novavax (NASDAQ:NVAX), Arena Pharmaceuticals (NASDAQ:ARNA), MannKind Corporation (NASDAQ:MNKD)